Edition:
United States

Oaktree Capital Group LLC (OAK)

OAK on New York Consolidated

48.15USD
25 Jul 2016
Change (% chg)

$0.24 (+0.50%)
Prev Close
$47.91
Open
$48.04
Day's High
$48.34
Day's Low
$47.75
Volume
107,936
Avg. Vol
223,679
52-wk High
$55.83
52-wk Low
$38.66

Select another date:

Thu, Jun 9 2016

Ireland's NAMA sells $5.3 bln loan portfolio to U.S. firm Oaktree -source

DUBLIN, June 9 Ireland's state-run "bad bank" selected U.S. private equity firm Oaktree Capital Group LLC as preferred bidder for two portfolios of non-performing loans that have a combined par value of 4.7 billion euros ($5.3 bln), a source close to the deal said on Thursday.

BRIEF-Oaktree Capital comments on Tribune Publishing-Gannett deal

* Believe it incumbent upon tribune publishing's board to establish an independent committee with its own independent advisors

BRIEF-Oaktree Capital Group files for potential mixed shelf offering

* Files for potential mixed shelf offering; size not disclosed - sec filing Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-Oaktree posts Qtrly net income $0.45/unit

* Qtrly assets under management were $96.9 billion, down 1% for quarter and 3 pct over last 12 months

Oaktree appoints banks for planned sale of SGD Pharma: sources

PARIS Oaktree Capital plans to sell its stake in SGD Pharma, a French company that specializes in making glass packaging for the pharmaceutical sector, and has mandated JP Morgan and Lazard to drive the process, two sources close to the deal told Reuters on Friday.

Oaktree appoints banks for planned sale of SGD Pharma -sources

PARIS, Feb 12 Oaktree Capital plans to sell its stake in SGD Pharma, a French company that specialises in making glass packaging for the pharmaceutical sector, and has mandated JP Morgan and Lazard to drive the process, two sources close to the deal told Reuters on Friday.

Select another date: